Abstract
THE major active ingredient of marijuana, Δ9-tetrahydrocannabi-nol (Δ9-THC), has been used as a psychoactive agent for thousands of years. Marijuana, and Δ9-THC, also exert a wide range of other effects including analgesia, anti-inflammation, immunosuppression, anticonvulsion, alleviation of intraocular pressure in glaucoma, and attenuation of vomiting1. The clinical application of cannabinoids has, however, been limited by their psychoactive effects, and this has led to interest in the biochemical bases of their action. Progress stemmed initially from the synthesis of potent derivatives of δ9-THC4,5, and more recently from the cloning of a gene encoding a G-protein-coupled receptor for cannabinoids6. This receptor is expressed in the brain but not in the periphery, except for a low level in testes. It has been proposed that the non-psychoactive effects of cannabinoids are either mediated centrally or through direct interaction with other, non-receptor proteins1,7,8. Here we report the cloning of a receptor for cannabinoids that is not expressed in the brain but rather in macrophages in the marginal zone of spleen.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dewey, W. L. Pharmac. Rev. 38, 151–178 (1986).
Howlett, A. C. et al. Trends Neurosci. 13, 420–432 (1990).
Hollister, L. E. Pharmac. Rev. 38, 1–20 (1986).
Razdan, R. K. Pharmac. Rev. 38, 75–149 (1986).
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S. & Howlett, A. C. Molec. Pharmacol. 34, 605–613 (1988).
Matsuda, L. A., Lolait, S. J., Brownstein, B. J., Young, A. C. & Bonner, T. I. Nature 356, 561–564 (1990).
Martin, B. R. Pharmac. Rev. 38, 45–74 (1986).
Reichman, M., Nen, W. & Hokin, L. E. Molec. Pharmac. 40, 547–555 (1991).
Collins, S. J. Blood 70, 1233–1244 (1987).
Lee, J. et al. J. biol. Chem. 267, 16283–16287 (1992).
Zhou, Q. Y. et al. Proc. natn. Acad. Sci. U.S.A. 89, 7432–7436 (1992).
Baldwin, J. M. EMBO J. 12, 1693–1703 (1993).
Jansen, E. M., Haycock, D. A., Ward, S. J. & Seybold V. S. Brain Res. 575, 93–102 (1992).
Devane, W. A. et al. J. med. Chem. 35, 2065–2069 (1992).
Herkenham, M. et al. Proc. natn. Acad. Sci. U.SA. 87, 1932–1936 (1990).
Devane, W. A. et al. Science 258, 1946–1949 (1992).
Sheets, M. D., Ogg, S. C. & Wickens, M. P. Nucleic. Acids Res. 18, 5799–5805 (1990).
Mailleux, P. & Vanderhaeghen, J.-J. Neuroscience 48, 655–668 (1992).
Kraal, G. Int. Rev. Cytol. 132, 31–74 (1992).
Humphrey, J. H. & Grennan, D. Eur. J. Immun. 11, 221–228 (1981).
Keshav, S., Chung, P., Milon, G. & Gordon, S. J. exp. Med. 174, 1049–1058 (1991).
Conklin, B. R. & Bourne, H. R. Cell 73, 631–641 (1993).
Munson, A. E. & Fehr, K. O. in Adverse Health and Behavioral Consequences of Cannabis Use (eds Fehr, K. O. & Kalant H.) 257–353 (Addiction Research Foundation, Toronto, 1983).
Schatz, A. R., Kessler, F. K. & Kaminski, N. E. Life Sci. 51, 25–30 (1992).
Lopez-Cepero, M., Friedman, M., Klein, T. & Friedman, H. J. Leukocyte Biol. 39, 679–686 (1986).
Hollister, L. E. J. Psychoactive Drugs 24, 159–164 (1992).
Fride, E. & Mechoulam, R. Eur. J. Pharmac. 231, 313–314 (1993).
Gerard, C. M., Mollereau, C., Vassart, G. & Parmentier, M. Biochem. J. 279, 129–134 (1991).
Simmons, D., Makgoba, M. W. & Seed, B. Nature 331, 624–627 (1988).
Seed, B. Nature 329, 840–842 (1987).
Robinson, A. P., White, T. M. & Mason, D. W. Immunology 57, 239–247 (1986).
Dallman, M. J., Thomas, M. L. & Green, J. R. Eur. J. Immun. 12, 511–518 (1982).
Shirasawa, T., Sakamoto, K., Akashi, T., Takahashi, H. & Kawashima, A. Nucleic Acids Res. 20, 909 (1992).
Wisden, W., Morris, B. J. & Hunt, S. P. in Molecular Neurobiology: a Practical Approach (eds Chad, J. & Wheal, H.) 205–225 (IRL at Oxford Univ. Press, Oxford, 1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Munro, S., Thomas, K. & Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61–65 (1993). https://doi.org/10.1038/365061a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/365061a0
This article is cited by
-
Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions
British Journal of Cancer (2024)
-
Repeated Δ-9-Tetrahydrocannabinol administration dose dependently increases stablished schedule-induced drinking
Psychopharmacology (2024)
-
Comprehensive analysis of 19 cannabinoids in commercial CBD oils: concentrations, profiles, and safety implications
Journal of Consumer Protection and Food Safety (2024)
-
Modulation of pulmonary immune function by inhaled cannabis products and consequences for lung disease
Respiratory Research (2023)
-
Potent dual MAGL/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain
The Journal of Headache and Pain (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.